


Healthcare Industry News: IIb/IIIa
News Release - July 31, 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Source: AstraZeneca
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
